KYMR
#950
Kymera Therapeutics, Inc. - Common Stock
114.1 2 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.82%
Monthly Change
+29.23%
6 month change
+69.80%
Year Change
+93.10%
Previous Close
112.0 8
Open
114.2 9
Low
114.1 2
High
114.2 9
Volume
92
Financials
- Market Capitalization 9.39 B
- Employee 253
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-23.27
Price to sales ratio
148.57
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 922 |  NUVL Nuvalent, Inc. - Class A Common Stock | 123.96 USD | 0.00% | +0.18% | +0.45% | +30.55% | 9.79 B USD | ||
| 935 |  CORT Corcept Therapeutics Incorporated - Common Stock | 89.57 USD | -0.99% | -2.86% | +6.25% | +22.08% | 9.62 B USD | ||
| 970 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 54.73 USD | -0.36% | -18.92% | -25.12% | -24.12% | 9.04 B USD | ||
| 975 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 75.82 USD | +1.03% | -5.74% | +8.87% | +13.50% | 8.99 B USD |
Frequently asked questions about Kymera Therapeutics, Inc. - Common Stock
What is the Kymera Therapeutics, Inc. - Common Stock stock price today?
The current price of Kymera Therapeutics, Inc. - Common Stock (KYMR) is 114.12. Over the past 24 hours, the stock has changed by +1.82%. Follow the KYMR chart for real-time price dynamics.
What is the stock ticker of Kymera Therapeutics, Inc. - Common Stock?
Kymera Therapeutics, Inc. - Common Stock trades under the ticker KYMR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kymera Therapeutics, Inc. - Common Stock stock going up?
KYMR has changed by -0.03% over the last week, +29.23% over the last month, and +93.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kymera Therapeutics, Inc. - Common Stock net income for the last quarter?
Kymera Therapeutics, Inc. - Common Stock reported net income of -69.23 M for the last quarter. The previous quarter showed -86.98 M, which means net income changed by +20.40%.
How many employees does Kymera Therapeutics, Inc. - Common Stock have?
As of the latest available data, Kymera Therapeutics, Inc. - Common Stock has 253 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kymera Therapeutics, Inc. - Common Stock EBITDA?
Kymera Therapeutics, Inc. - Common Stock EBITDA is -116.5 M, and its EBITDA margin is -339%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kymera Therapeutics, Inc. - Common Stock stock?
You can buy Kymera Therapeutics, Inc. - Common Stock (KYMR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kymera Therapeutics, Inc. - Common Stock stock?
Investing in Kymera Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYMR chart and related analysis on metatrader.com as part of your research.